Arata Yuka, Tanabe Katsuyuki, Hinamoto Norikazu, Yamasaki Hiroko, Sugiyama Hitoshi, Maeshima Yohei, Kanomata Naoki, Sato Yasufumi, Wada Jun
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Acta Med Okayama. 2017 Oct;71(5):369-380. doi: 10.18926/AMO/55434.
Several angiogenesis-related factors are known to play important roles in the pathogenesis of kidney disease. Vasohibin-2 (VASH-2) was recently reported as a novel proangiogenic factor. Although VASH-2 was demonstrated to accelerate tumor angiogenesis, its roles in non-tumor processes including renal disease have not been well elucidated yet. Here, we performed a retrospective study including an immunohistochemical analysis of human kidney biopsy specimens from 82 Japanese patients with a variety of kidney diseases, and we evaluated the correlations between the immunoreactivity of VASH-2 and the patients' clinicopathological parameters. VASH-2 immunoreactivity was detected in varying degrees in renal tubules as well as in peritubular capillaries and vasa recta. The cortical and medullary tubule VASH-2+ scores were correlated with the presence of hypertension, and the medullary tubule VASH-2+ score was significantly correlated with the blood glucose (p=0.029, r=0.35) and hemoglobin A1c levels (p=0.0066, r=0.39). Moreover, decreased VASH-2+ scores in the vasa recta were associated with reduced renal function (p=0.0003). These results suggest that VASH-2 could play an important role in the pathogenesis of renal diseases, and that VASH-2 is closely associated with hypertension and impaired glucose tolerance.
已知几种血管生成相关因子在肾脏疾病的发病机制中起重要作用。血管抑制素-2(VASH-2)最近被报道为一种新的促血管生成因子。尽管VASH-2已被证明可加速肿瘤血管生成,但其在包括肾脏疾病在内的非肿瘤过程中的作用尚未得到充分阐明。在此,我们进行了一项回顾性研究,包括对82例患有各种肾脏疾病的日本患者的肾活检标本进行免疫组织化学分析,并评估VASH-2的免疫反应性与患者临床病理参数之间的相关性。在肾小管以及肾小管周围毛细血管和直小血管中均不同程度地检测到VASH-2免疫反应性。皮质和髓质肾小管VASH-2+评分与高血压的存在相关,髓质肾小管VASH-2+评分与血糖(p=0.029,r=0.35)和糖化血红蛋白水平(p=0.0066,r=0.39)显著相关。此外,直小血管中VASH-2+评分降低与肾功能下降相关(p=0.0003)。这些结果表明,VASH-2可能在肾脏疾病的发病机制中起重要作用,并且VASH-2与高血压和糖耐量受损密切相关。